ACTIVE

Perrigo Holding

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
63,3 M €
+90,3 %over 1 year
Revenue
48,4 M €
+34,8 %over 1 year
Equity
1,5 Md €
+1,7 %over 1 year
Workforce
37,7 ETP
-3,1 %over 1 year

Identity

Source · BCE/KBO

Perrigo Holding is a Public limited company incorporated in 1987. Its main activity is: Activities of holding companies. Its registered office is in Gent. It employs on average 37,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0431.676.229
Incorporation
27/07/1987
Legal form
Public limited company
Registered office
Gaston Crommenlaan 6 box 606
9050 Gent · FlandreSee on map
Contributed capital
1 358 048 567,00 €
Latest accounts
31/12/2025
Average workforce
37,7 ETP
Joint committees (5)
  • 100
  • 116
  • 200
  • 207
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 31 filings

Trend over 18 financial years

20252023202220212020
Income statement
Revenue48,4 M €35,9 M €33,6 M €45,4 M €47,1 M €
EBITDA18,8 M €-11,1 M €-6,9 M €7,3 M €-9,7 M €
Operating result13,3 M €-15,5 M €-11,4 M €5,2 M €-10,6 M €
Net result63,3 M €33,3 M €1,1 M €109,7 M €-204,8 M €
Balance sheet
Equity1,5 Md €1,5 Md €1,5 Md €1,2 Md €1,2 Md €
Total assets1,6 Md €1,7 Md €1,7 Md €1,6 Md €1,5 Md €
Cash–1,7 k €1,8 k €1,4 k €1,2 k €
Debts108,1 M €181,6 M €156,5 M €365,5 M €295,6 M €
Other
Workforce37,7 ETP38,9 ETP41,6 ETP42,4 ETP46,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 77 ended

Active mandates

Jonas Dhaenens

Director · since 22 mai 2026 · until 13 mai 2032

Active
Sonia Hollies

Director · since 13 mai 2024 · until 09 mai 2030

Active
Magali Verbraecken

Director · since 27 janvier 2023 · until 27 janvier 2029

Active
Anja van Winsberghe

Director · since 03 mai 2021 · until 22 mai 2026

Active

Ended mandates

Magali Verbraecken

Director · since 27 janvier 2023 · until 10 mai 2029

Ended
Christophe Van Damme

Director · since 29 juillet 2021 · until 13 mai 2027

Ended
Gianluca Parola

Director · since 29 juillet 2021 · until 13 mai 2027

Ended
Anja van Winsberghe

Director · since 03 mai 2021 · until 13 mai 2027

Ended

Other companies at this address

Gaston Crommenlaan 6 9050 Gent
CompanyCBE no.
BRAVX● Active
0834.939.871
LIGHTHOUSE INTELLIGENCE● Active
0676.420.293
Oce-Bio● Active
0442.861.022
omega pharma group● Active
0837.048.632
OMEGA PHARMA INNOVATION & DEVELOPMENT● Active
0884.084.724
OMEGA PHARMA INTERNATIONAL● Active
0807.596.363
OMEGA PHARMA TRADING● Active
0417.092.080
Perrigo Belgium● Active
0417.132.860
Perrigo Capital● Active
0430.784.027
Perrigo Europe Invest● Active
0439.658.834
TM BRAVO4 CIVIEL● Active
0787.232.501
TM BRAVO-4 KOEPEL-EPC● Active
1008.974.796
TM Goedingebrug● Active
1039.143.281
TM Nieuwe Waasmunsterbrug over Durme● Active
1035.016.328

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date06/07/202625/06/202522/05/202431/05/202316/06/202214/06/2021
General meeting29/06/202620/05/202513/05/202411/05/202312/05/202217/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 31 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202529/06/202606/07/2026DutchPDF
Full model31/12/202420/05/202525/06/2025DutchPDF
Full model31/12/202313/05/202422/05/2024DutchPDF
Full model31/12/202211/05/202331/05/2023DutchPDF
Full model31/12/202112/05/202216/06/2022DutchPDF
Full model31/12/202017/05/202114/06/2021DutchPDF
Full model31/12/201914/05/202012/06/2020DutchPDF
Full model31/12/201823/04/201921/05/2019DutchPDF
Full model31/12/201724/04/201822/05/2018DutchPDF
Full model31/12/201616/05/201712/06/2017DutchPDF
Consolidated accounts31/12/201616/05/201720/06/2017DutchPDF
Full model31/12/201520/05/201617/06/2016DutchPDF
Consolidated accounts31/12/201522/07/201627/07/2016DutchPDF
Full model31/12/201428/04/201527/05/2015DutchPDF
Consolidated accounts31/12/201428/04/201527/05/2015DutchPDF
Full model31/12/201322/04/201412/05/2014DutchPDF
Consolidated accounts31/12/201322/04/201412/05/2014DutchPDF
Full model31/12/201223/04/201321/05/2013DutchPDF
Consolidated accounts31/12/201223/04/201323/05/2013DutchPDF
Full model31/12/201120/04/201215/05/2012DutchPDF
Consolidated accounts31/12/201120/04/201215/05/2012DutchPDF
Full model31/12/201002/05/201119/05/2011DutchPDF
Consolidated accounts31/12/201002/05/201126/05/2011DutchPDF
Full model31/12/200903/05/201027/05/2010DutchPDF

View all 31 filings

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 77 ended

Active mandates

Jonas Dhaenens

Director · since 22 mai 2026 · until 13 mai 2032

Active
Sonia Hollies

Director · since 13 mai 2024 · until 09 mai 2030

Active
Magali Verbraecken

Director · since 27 janvier 2023 · until 27 janvier 2029

Active
Anja van Winsberghe

Director · since 03 mai 2021 · until 22 mai 2026

Active

Ended mandates

Magali Verbraecken

Director · since 27 janvier 2023 · until 10 mai 2029

Ended
Christophe Van Damme

Director · since 29 juillet 2021 · until 13 mai 2027

Ended
Gianluca Parola

Director · since 29 juillet 2021 · until 13 mai 2027

Ended
Anja van Winsberghe

Director · since 03 mai 2021 · until 13 mai 2027

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates09/06/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates21/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring25/07/2024
    DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates18/06/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring15/03/2024
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Registered office07/03/2024
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates10/10/2023
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 22/05/2026
    nominationJonas Dhaenens — bestuurder
  2. 2025
    Annual accounts 202563,3 M €↑
  3. 20/05/2025
    nominationBDO Bedrijfsrevisoren BV — commissaris
  4. 13/05/2024
    nominationSonia Hollies — bestuurder
  5. 2023
    Annual accounts 202333,3 M €↑
  6. 27/01/2023
    nominationMagali Verbraeken — bestuurder
  7. 2022
    Annual accounts 20221,1 M €↓
  8. 20/06/2022
    augmentation_capital
  9. 2021
    Annual accounts 2021109,7 M €↑
  10. 2020
    Annual accounts 2020-204,8 M €↓
  11. 2019
    Annual accounts 2019-109,2 M €↓
  12. 2019
    Name changePERRIGO HOLDING NV
  13. 2018
    Annual accounts 2018-145,2 k €↓
  14. 2017
    Annual accounts 20171,9 M €↑
  15. 2016
    Annual accounts 2016-25,6 M €↓
  16. 2015
    Annual accounts 2015-16,7 M €↓
  17. 2014
    Annual accounts 201446,9 M €↑
  18. 2013
    Annual accounts 20131,8 M €↓
  19. 2012
    Annual accounts 201281,9 M €↑
  20. 2011
    Annual accounts 201164,9 M €↑
  21. 2010
    Annual accounts 201037,7 M €↑
  22. 2009
    Annual accounts 2009-15,2 M €↓
  23. 2008
    Annual accounts 20081,3 M €↓
  24. 2006
    Annual accounts 2006178,3 M €
  25. 2006
    Name changeOMEGA PHARMA
  26. 27/07/1987
    IncorporationPublic limited company